Correctors modify the bicarbonate permeability of F508del-CFTR

被引:22
|
作者
Fiore, Michele [1 ]
Picco, Cristiana [1 ]
Moran, Oscar [1 ]
机构
[1] CNR, Ist Biofis, Via Marini 6, I-16149 Genoa, Italy
关键词
TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; CHLORIDE CHANNELS; CFTR; DELTA-F508; EXPRESSION; SECRETION; MECHANISM; MEMBRANE; MUTATION;
D O I
10.1038/s41598-020-65287-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
One of the most common mutations in Cystic Fibrosis (CF) patients is the deletion of the amino acid phenylalanine at position 508. This mutation causes both the protein trafficking defect and an early degradation. Over time, small molecules, called correctors, capable of increasing the amount of mutated channel in the plasma membrane and causing an increase in its transport activity have been developed. This study shows that incubating in vitro cells permanently transfected with the mutated channel with the correctors VX809, VX661 and Corr4a, and the combination of VX809 and Corr4a, a recovery of anion transport activity is observed. Interestingly, the permeability of bicarbonate increases in the cells containing corrected p.F508del CFTR channels is greater than the increase of the halide permeability. These different increases of the permeability of bicarbonate and halides are consistent with the concept that the structural conformation of the pore of the corrector-rescued p.F508del channels would be different than the normal wild type CFTR protein.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] COMBINATION OF CORRECTORS AND POTENTIATORS FOR F508DEL CFTR
    Rowe, Steven M.
    Boyle, Michael P.
    PEDIATRIC PULMONOLOGY, 2011, : 180 - 181
  • [22] Ouabain mimics low temperature rescue of F508del-CFTR in cystic fibrosis epithelial cells
    Zhang, Donglei
    Ciciriello, Fabiana
    Anjos, Suzana M.
    Carissimo, Annamaria
    Liao, Jie
    Carlile, Graeme W.
    Balghi, Haouaria
    Robert, Renaud
    Luini, Alberto
    Hanrahan, John W.
    Thomas, David Y.
    FRONTIERS IN PHARMACOLOGY, 2012, 3
  • [23] Reply to 'F508del-CFTR is not corrected by thymosin α1'
    Romani, Luigina
    Stincardini, Claudia
    Giovagnoli, Stefano
    Paci, Maurizio
    Villella, Valeria R.
    Sforna, Luigi
    Renga, Giorgia
    Bellet, Marina M.
    Costantini, Claudio
    Puccetti, Paolo
    Kroemer, Guido
    Maiuri, Luigi
    Pessia, Mauro
    Goldstein, Allan
    Garaci, Enrico
    NATURE MEDICINE, 2018, 24 (07) : 891 - 893
  • [24] Deciphering the role of protein kinase CK2 in the maturation/stability of F508del-CFTR
    D'Amore, Claudio
    Borgo, Christian
    Bosello-Travain, Valentina
    Vilardell, Jordi
    Salizzato, Valentina
    Pinna, Lorenzo A.
    Venerando, Andrea
    Salvi, Mauro
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (03):
  • [25] Proteomics uncovering possible key players in F508del-CFTR processing and trafficking
    Gomes-Alves, Patricia
    Penque, Deborah
    EXPERT REVIEW OF PROTEOMICS, 2010, 7 (04) : 487 - 494
  • [26] Proteomic interaction profiling reveals KIFC1 as a factor involved in early targeting of F508del-CFTR to degradation
    Canato, Sara
    Santos, Joao D.
    Carvalho, Ana S.
    Aloria, Kerman
    Amaral, Margarida D.
    Matthiesen, Rune
    Falcao, Andre O.
    Farinha, Carlos M.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2018, 75 (24) : 4495 - 4509
  • [27] S-Nitrosylation of CHIP Enhances F508Del-CFTR Maturation
    Zaman, Khalequz
    Knight, Julia
    Hussain, Faraaz
    Cao, Ruofan
    Estabrooks, Samuel K.
    Altawallbeh, Ghaith
    Holloway, Kristopher
    Jafri, Anjum
    Sawczak, Victoria
    Li, Yuejin
    Getsy, Paulina
    Sun, Fei
    Raffay, Thomas
    Cotton, Calvin
    Brodsky, Jeffrey L.
    Periasamy, Ammasi
    Lewis, Stephen J.
    Gaston, Benjamin
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2019, 61 (06) : 765 - 775
  • [28] Effects of Lumacaftor/Ivacaftor in a Pediatric Cohort Homozygous for F508del-CFTR
    Egan, Marie E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (07) : 849 - 850
  • [29] Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR
    Donaldson, Scott H.
    Pilewski, Joseph M.
    Griese, Matthias
    Cooke, Jon
    Viswanathan, Lakshmi
    Tullis, Elizabeth
    Davies, Jane C.
    Lekstrom-Himes, Julie A.
    Wang, Linda T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (02) : 214 - 224
  • [30] Chronic ivacaftor treatment: Getting F508del-CFTR into more trouble?
    Mall, Marcus A.
    Sheppard, David N.
    JOURNAL OF CYSTIC FIBROSIS, 2014, 13 (06) : 605 - 607